Motus GI to Release Second Quarter 2020 Results and Provide a Business Update on August 11th
Motus GI Holdings, Inc. (NASDAQ: MOTS), a medical technology company focused on gastrointestinal endoscopy solutions, is set to release its second-quarter 2020 financial results on August 11, 2020, after market close. The management will host a conference call and webcast at 4:30 p.m. ET to discuss these results and provide updates on corporate developments. The press release emphasizes the company's commitment to improving clinical outcomes and cost efficiency in gastrointestinal diagnostics and management.
- Anticipated financial results release on August 11, 2020, allowing for investor insights.
- Management will provide updates on corporate developments during the conference call.
- No specific financial metrics or guidance provided for the upcoming financial results.
FORT LAUDERDALE, Fla., July 21, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that the Company will release its second quarter 2020 financial results on Tuesday, August 11, 2020, after the market close. Management will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide updates on recent corporate developments.
18%; width: | 82%; width: |
Date and Time: | Tuesday, August 11th at 4:30 p.m. ET |
Domestic: | 877-407-0792 |
International: | 201-689-8263 |
Passcode: | 13705843 |
Webcast: | www.motusgi.com or http://public.viavid.com/index.php?id=140402 |
A replay of the webcast will be archived on the Motus GI website, www.motusgi.com, for 90 days following the event.
About Motus GI
Motus GI Holdings, Inc. is a medical technology company, with subsidiaries in the U.S. and Israel, providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions.
For more information, visit www.motusgi.com and connect with the Company on Twitter, LinkedIn and Facebook.
Investor Contact:
Bob Yedid
LifeSci Advisors
(646) 597-6989
bob@lifesciadvisors.com
FAQ
When will Motus GI release its second-quarter 2020 financial results?
What time is the Motus GI conference call scheduled for?
What is the purpose of the Motus GI conference call?
How can I access the Motus GI webcast?